Evidence map›Paper›PMID 36497250›Full record

ReviewCancers2022

Epigenetic Regulation in Chromium-, Nickel- and Cadmium-Induced Carcinogenesis.

Lei Zhao, Ranakul Islam, Yifang Wang, Xiujuan Zhang, Ling-Zhi Liu

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Impact Assessment and Sustainable Remediation of Heavy Metal and Radioactive Contamination in Aquatic Systems: A Review.Water environment research : a research publication of the Water Environment Federation · 2026
    Review
  3. BCL-2 and BCL-xL in Cancer: Regulation, Function, and Therapeutic Targeting.International journal of molecular sciences · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Bioaccumulation Capacity of Onion (Molecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lei ZhaoDepartment of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Ranakul IslamDepartment of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0000-0001-9384-3231
Yifang WangDepartment of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Xiujuan ZhangDepartment of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Ling-Zhi LiuDepartment of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0000-0001-9234-457X
Thomas Jefferson University · US

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI Claudio Guillermo Giraudo · 1995 to 2026
$94.8M
Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatmentsR01CA232587 · NCI · UNIVERSITY OF IOWA · PI SIMONE, NICOLE L · 2018 to 2022
$2.9M
MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment responseR01CA263506 · NCI · THOMAS JEFFERSON UNIVERSITY · PI Jun He · 2022 to 2026
$2.8M
METTL3 in chromium-induced angiogenesis and carcinogenesisR01ES033197 · NIEHS · THOMAS JEFFERSON UNIVERSITY · PI STEVEN B. MCMAHON · 2022 to 2026
$2.6M
New Mechanism of Arsenic CarcinogenesisK02ES029119 · NIEHS · UNIVERSITY OF IOWA · PI LIU, LING-ZHI · 2018 to 2022
$613k
American Cancer Society RSG-16-052-01-NECCommonwealth University Research Enhancement Program grant with the Pennsylvania De-partment of Health SAP#4100088563NCI NIH HHS NIH 5P30CA056036NCI NIH HHS P30 CA056036NCI NIH HHS R01 CA232587NCI NIH HHS R01CA232587NCI NIH HHS R01 CA263506NCI NIH HHS R01CA263506NIEHS NIH HHS K02 ES029119NIEHS NIH HHS K02ES029119NIEHS NIH HHS R01 ES033197NIEHS NIH HHS R01ES033197
6 · The paper itself

Abstract

Environmental and occupational exposure to heavy metals, such as hexavalent chromium, nickel, and cadmium, are major health concerns worldwide. Some heavy metals are well-documented human carcinogens. Multiple mechanisms, including DNA damage, dysregulated gene expression, and aberrant cancer-related signaling, have been shown to contribute to metal-induced carcinogenesis. However, the molecular mechanisms accounting for heavy metal-induced carcinogenesis and angiogenesis are still not fully understood. In recent years, an increasing number of studies have indicated that in addition to genotoxicity and genetic mutations, epigenetic mechanisms play critical roles in metal-induced cancers. Epigenetics refers to the reversible modification of genomes without changing DNA sequences; epigenetic modifications generally involve DNA methylation, histone modification, chromatin remodeling, and non-coding RNAs. Epigenetic regulation is essential for maintaining normal gene expression patterns; the disruption of epigenetic modifications may lead to altered cellular function and even malignant transformation. Therefore, aberrant epigenetic modifications are widely involved in metal-induced cancer formation, development, and angiogenesis. Notably, the role of epigenetic mechanisms in heavy metal-induced carcinogenesis and angiogenesis remains largely unknown, and further studies are urgently required. In this review, we highlight the current advances in understanding the roles of epigenetic mechanisms in heavy metal-induced carcinogenesis, cancer progression, and angiogenesis.

Indexed as

angiogenesiscarcinogenesisDNA methylationepigeneticsheavy metalhistone modificationnon-coding RNA

Identifiers

PMID36497250
PMCPMC9737485
OpenAlexW4310043247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.